NovaBridge Biosciences (NBP) — Tangible Net Worth Ratio
NovaBridge Biosciences (NBP) has a Tangible Net Worth Ratio of 100.0% as of September 2025. This metric is calculated by deducting intangible assets ($0.00) from net assets ($1.84 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See NovaBridge Biosciences shareholders equity for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
NovaBridge Biosciences Tangible Net Worth Ratio (2020–2024)
This chart shows how NovaBridge Biosciences's Tangible Net Worth Ratio has changed across 5 annual periods from 2020 to 2024. As of September 2025, the ratio stands at 100.0%, reflecting net assets of $1.84 Billion with intangible assets of $0.00 USD. Also explore net asset growth rate of NovaBridge Biosciences to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for NovaBridge Biosciences (2020–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for NovaBridge Biosciences from 2020 to 2024, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see NovaBridge Biosciences market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 100.0% | $201.16 Million | $0.00 | $212.68 Million | ▲ +1.0 pp |
| 2023 | 99.0% | $1.72 Billion | $16.66 Million | $2.61 Billion | ▲ +3.0 pp |
| 2022 | 96.0% | $3.01 Billion | $118.89 Million | $4.07 Billion | ▼ -1.3 pp |
| 2021 | 97.4% | $4.59 Billion | $119.67 Million | $5.63 Billion | ▼ -0.5 pp |
| 2020 | 97.9% | $5.63 Billion | $120.44 Million | $6.33 Billion | — |